Open AccessDrug Reaction with eosinophilia and systemic symptoms with alopecia universalis and vitiligo
Author(s) -
Ives Alexandre Yutani Koseki,
Débora Sarzi Sartori,
Isabelle Maffei Guarenti,
Fábio Yutani Koseki,
Amanda Dagostim Gietner,
Simoni Euzébio Nunes
Publication year - 2021
Publication title -
medicina
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.104
H-Index - 10
eISSN - 2176-7262
pISSN - 0076-6046
DOI - 10.11606/issn.2176-7262.rmrp.2021.179965
Subject(s) - alopecia universalis , vitiligo , medicine , alopecia areata , dermatology , eosinophilia , drug , immunology , psychiatry
Drug reactions with eosinophilia and systemic symptoms (DRESS) are rare and potentially fatal adverse hypersensitivity reaction to some drugs, especially anticonvulsants. The syndrome affects not only the skin but also other organs, especially the liver. The incidence can vary from 1 to 5 cases per 10.000 patients exposed to anticonvulsants.The recognition of the syndrome is of fundamental importance since the mortality rate is between 10 and 40%. Once the diagnosis is established, the triggering drug must be identified and discontinued. Corticosteroids are usually associated with therapy. Autoimmune sequelae have been reported, including vitiligo and rarely alopecia. Alopecia universalis is a variant of alopecia areata, characterized by hair loss throughout the body. We report a case of DRESS, associated with two autoimmune dermatological diseases: alopecia universalis and vitiligo.